Literature DB >> 20934711

Prolonged cold ischemic time results in increased acute rejection in a rat allotransplantation model.

Bo Xiao1, Wei Xia, Jin Zhang, Bei Liu, Shuzhong Guo.   

Abstract

BACKGROUND: The cold ischemic time may be more prolonged for facial tissue allografts than for organ allografts. Previous researches have shown that prolonged ischemia resulted in increased signs of rejection in a rat groin allotransplantation model; however, the relationship between cold ischemia and alloantigen-induced rejection was unclear.
MATERIALS AND METHODS: Vascularized groin flaps were transplanted from BN to Lewis rats after 0, 6, 12, 18, or 24 h of storage at 4 °C, and the allografts in each group were evaluated daily. Biopsy samples taken from the allo-0 h and allo-24 h groups on postoperative d 2-8 were graded for signs of acute rejection. Biopsy samples taken from the allo-0 h and allo-24 h groups on postoperative d 5 were stained for chemokine receptor CXCR3.
RESULTS: When the cold ischemia time was greater than 18 h, the survival time of the grafts was significantly shorter (6.2 ± 1.3 d) than that of the grafts that did not undergo cold ischemia (9.0 ± 1.2 d). Histological valuation showed acceleration of activated lymphocyte infiltration in the allo-24 h group (2.2 ± 0.4 d) compared with the allo-0 h group (4.8 ± 0.4 d). Furthermore, the proportion of CXCR3-positive cells in the allo-24 h group (49.7% ± 6.0%) was significantly higher than that in the allo-0 h group (22.9% ± 3.4%) on d 5 after transplantation.
CONCLUSIONS: Prolonged ischemia has a deleterious effect on allograft survival, and the chemokine receptor CXCR3 may play a role in this process.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20934711     DOI: 10.1016/j.jss.2010.08.012

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  5 in total

1.  Targeted Complement Inhibition Protects Vascularized Composite Allografts From Acute Graft Injury and Prolongs Graft Survival When Combined With Subtherapeutic Cyclosporine A Therapy.

Authors:  Peng Zhu; Stefanie R Bailey; Biao Lei; Chrystal M Paulos; Carl Atkinson; Stephen Tomlinson
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

2.  Current status of vascularized composite tissue allotransplantation.

Authors:  Karoline Edtinger; Xiaoyong Yang; Hanae Uehara; Stefan G Tullius
Journal:  Burns Trauma       Date:  2014-04-06

Review 3.  Application of hyperbaric oxygen in liver transplantation.

Authors:  Hu Lv; Cui-Hong Han; Xue-Jun Sun; Wen-Wu Liu
Journal:  Med Gas Res       Date:  2016-12-30

4.  Evaluation of Early Markers of Ischemia-reperfusion Injury and Preservation Solutions in a Modified Hindlimb Model of Vascularized Composite Allotransplantation.

Authors:  Sara Rostami; Michael Xu; Shaishav Datta; Siba Haykal
Journal:  Transplant Direct       Date:  2021-12-13

Review 5.  Improving the ischemia-reperfusion injury in vascularized composite allotransplantation: Clinical experience and experimental implications.

Authors:  Jiqiang He; Umar Zeb Khan; Liming Qing; Panfeng Wu; Juyu Tang
Journal:  Front Immunol       Date:  2022-09-16       Impact factor: 8.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.